Ticker
RGNXCompany Name
REGENXBIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Dividends & Other Cash Distributions | Payout Yield |
---|---|---|---|---|
6/30/2025 | $ 399.06M | $ 884K | $ 0 | -0.22% |
3/31/2025 | $ 399.78M | $ 861K | $ 0 | -0.22% |
12/31/2024 | $ 328.06M | $ 133.45M | $ 0 | -40.68% |
9/30/2024 | $ 467.21M | $ 133.94M | $ 0 | -28.67% |
6/30/2024 | $ 657.82M | $ 139.26M | $ 0 | -21.17% |
3/31/2024 | $ 821.1M | $ 140.06M | $ 0 | -17.06% |
12/31/2023 | $ 889.44M | $ 8.22M | $ 0 | -0.92% |
9/30/2023 | $ 721.91M | $ 8.05M | $ 0 | -1.12% |
6/30/2023 | $ 830.85M | $ 3.88M | $ 0 | -0.47% |
3/31/2023 | $ 879.32M | $ 4.64M | $ 0 | -0.53% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends) / Market Cap
(=) Payout Yield
Payout Yield for REGENXBIO INC is calculated as follows: (-1 * CF - Equity [ $ 7.59M ] -1 * CF - Dividends [ $ 0 ]) / Market Cap [ $ 1.16B ]
(=) Payout Yield [ -0.65% ]
Minimum
Dec 31, 2024
Maximum
Mar 31, 2025
Average
Median
filtered constituents | 3.53K |
---|---|
min | -15.69% |
max | 16.92% |
average | 1.82% |
median | 1.33% |
std | 5.1% |